Generic Actos Study Shows No Bladder Cancer

Despite Personal Injury Lawsuits, Double-Blind Study Shows No Bladder Cancer from Generic Actos The generic form of Actos, pioglitazone, was approved for use by the FDA last August. The approval caused a huge outcry from Actos opponents, including many who are plaintiffs in personal injury lawsuits against Takeda Pharmaceuticals after taking … [Read more...]

Skip Generic Actos, for Health and Legal Reasons

Earlier this month, despite numerous lawsuits against Takeda Pharmaceuticals Actos, the FDA approved pioglitazone – the generic name for Actos – for market in the United States. Now, watchdog group Consumer Reports says the “bargain” should be avoided. For one thing, Consumer Reports points out, the generic version will not currently save patients … [Read more...]

Generic Version of Actos Approved for Market by the FDA

On Friday, August 17th, the FDA approved generic pioglitazone, which the highly controversial Actos is based on. The drug company approved to manufacture the generic drug is Mylan Pharmaceuticals, based in Morgantown, West Virginia. Meanwhile, the FDA is being sued by Watson Pharmaceuticals for the rights to the generic version of Actos. In … [Read more...]

Drug Manufacturer Watson Sues FDA Over Generic Actos Release

Watson Pharmaceuticals has filed a lawsuit against the FDA for denying shared exclusivity, despite the fact that the drug company followed all the FDA’s requirements. Watson planned to release the generic version of Takeda Pharmaceutical’s controversial Actos drug on August 17th. In 2010, Watson got approval to market the generic pioglitazone … [Read more...]

BestLawyers.comAVBetter Business Bureau